- Home
- NAII vs PULM Comparison
NAII vs PULM Comparison
Compare NAII & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAII
- PULM
- Stock Information
- Founded
- NAII 1980
- PULM 2003
- Country
- NAII United States
- PULM United States
- Employees
- NAII N/A
- PULM N/A
- Industry
- NAII Medicinal Chemicals and Botanical Products
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- NAII Health Care
- PULM Health Care
- Exchange
- NAII Nasdaq
- PULM Nasdaq
- Market Cap
- NAII 21.2M
- PULM 20.5M
- IPO Year
- NAII 1987
- PULM N/A
- Fundamental
- Price
- NAII $3.61
- PULM $5.33
- Analyst Decision
- NAII
- PULM
- Analyst Count
- NAII 0
- PULM 0
- Target Price
- NAII N/A
- PULM N/A
- AVG Volume (30 Days)
- NAII 3.9K
- PULM 9.1K
- Earning Date
- NAII 09-26-2025
- PULM 08-12-2025
- Dividend Yield
- NAII N/A
- PULM N/A
- EPS Growth
- NAII N/A
- PULM N/A
- EPS
- NAII N/A
- PULM N/A
- Revenue
- NAII $125,483,000.00
- PULM $1,921,000.00
- Revenue This Year
- NAII N/A
- PULM N/A
- Revenue Next Year
- NAII N/A
- PULM $134.88
- P/E Ratio
- NAII N/A
- PULM N/A
- Revenue Growth
- NAII 4.39
- PULM N/A
- 52 Week Low
- NAII $2.57
- PULM $1.78
- 52 Week High
- NAII $6.88
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- NAII 56.20
- PULM 33.68
- Support Level
- NAII $3.33
- PULM $5.20
- Resistance Level
- NAII $3.66
- PULM $5.77
- Average True Range (ATR)
- NAII 0.15
- PULM 0.29
- MACD
- NAII 0.01
- PULM -0.03
- Stochastic Oscillator
- NAII 58.70
- PULM 9.93
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).